spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scaffidi, A. K.
Right arrow Articles by Knight, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scaffidi, A. K.
Right arrow Articles by Knight, D. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
Journal of Cell Science 114, 3507-3516 (2001)
© 2001 The Company of Biologists Limited


RESEARCH ARTICLE

Regulation of human lung fibroblast phenotype and function by vitronectin and vitronectin integrins

Amelia K. Scaffidi1,2, Yuben P. Moodley1,2, Markus Weichselbaum1,2, Philip J. Thompson1,2 and Darryl A. Knight1,2,*

1 Asthma and Allergy Research Institute, Nedlands, Western Australia, 6009
2 Department of Medicine, University of Western Australia, Nedlands, Western Australia, 6009

*Author for correspondence (e-mail: dknight{at}cyllene.uwa.edu.au)

Accepted June 25, 2001

Myofibroblasts, characterised by high expression of {alpha}-smooth muscle actin ({alpha}-SMA), are important and transient cells in normal wound healing but are found in increased number in various pathological conditions of the lung including asthma and pulmonary fibrosis. The mechanisms that regulate the myofibroblast phenotype are unknown but are likely to involve signals from the extracellular matrix transmitted via specific integrins. Vitronectin is a glycoprotein released during inflammation and has been shown to regulate the phenotype of vascular smooth muscle cells via {alpha}v and ß1 integrins. In the current study we have examined whether vitronectin influences the phenotype and function of normal human lung fibroblasts (HFL-1). Incubation of HFL-1 cells with vitronectin induced a concentration-dependent reduction in {alpha}-SMA expression. By contrast, function-blocking monoclonal antibodies to the vitronectin integrins {alpha}v, ß1, {alpha}vß3 and {alpha}vß5 induced the expression of {alpha}-SMA and its organization into stress fibers. Expression of {alpha}-SMA induced by all function-blocking monoclonal antibodies was abrogated by inhibition of protein kinase C and phosphatidylinositol-3 kinase, but the effects of inhibition of other signalling pathways was integrin dependent. Exposure to other extracellular matrix proteins such as fibronectin, collagen or their integrins did not influence expression of {alpha}-SMA. The expression and organization of {alpha}-SMA induced by exposure to function-blocking antibodies was translated into an augmented capacity of HFL-1 cells to contract fibroblast populated collagen gels. By contrast, contraction of collagen gels following incubation with vitronectin was not significantly different to control. This study has shown that vitronectin influences the phenotype and behaviour of HFL-1 cells by downregulating the expression of {alpha}-SMA and reducing their contractile ability. By contrast, occupancy of specific integrins by function-blocking antibodies upregulated the expression of {alpha}-SMA and induced the formation of functional stress fibers capable of contracting collagen gels. These results suggest that vitronectin modulates the fibroblast-myofibroblast phenotype, implying an important role in the remodelling process during lung development or response to injury.

Key words: Extracellular matrix, Fibroblast, Asthma, Integrin, Remodeling, Fibroblast


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
D. V. Pechkovsky, A. K. Scaffidi, T. L. Hackett, J. Ballard, F. Shaheen, P. J. Thompson, V. J. Thannickal, and D. A. Knight
Transforming Growth Factor {beta}1 Induces {alpha}v{beta}3 Integrin Expression in Human Lung Fibroblasts via a {beta}3 Integrin-, c-Src-, and p38 MAPK-dependent Pathway
J. Biol. Chem., May 9, 2008; 283(19): 12898 - 12908.
[Abstract] [Full Text] [PDF]


Home page
JDRHome page
H.E. van Beurden, J.W. Von den Hoff, R. Torensma, J.C. Maltha, and A.M. Kuijpers-Jagtman
Myofibroblasts in Palatal Wound Healing: Prospects for the Reduction of Wound Contraction after Cleft Palate Repair
Journal of Dental Research, October 1, 2005; 84(10): 871 - 880.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
L. A. Weiss, L. A. Lester, J. E. Gern, R. L. Wolf, R. Parry, R. F. Lemanske, J. Solway, and C. Ober
Variation in ITGB3 Is Associated with Asthma and Sensitization to Mold Allergen in Four Populations
Am. J. Respir. Crit. Care Med., July 1, 2005; 172(1): 67 - 73.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Laplante, M.-A. Raymond, G. Gagnon, N. Vigneault, A. M.-J. Sasseville, Y. Langelier, M. Bernard, Y. Raymond, and M.-J. Hebert
Novel Fibrogenic Pathways Are Activated in Response to Endothelial Apoptosis: Implications in the Pathophysiology of Systemic Sclerosis
J. Immunol., May 1, 2005; 174(9): 5740 - 5749.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. K. Scaffidi, N. Petrovic, Y. P. Moodley, M. Fogel-Petrovic, K. M. Kroeger, R. M. Seeber, K. A. Eidne, P. J. Thompson, and D. A. Knight
{alpha}v{beta}3 Integrin Interacts with the Transforming Growth Factor {beta} (TGF{beta}) Type II Receptor to Potentiate the Proliferative Effects of TGF{beta}1 in Living Human Lung Fibroblasts
J. Biol. Chem., September 3, 2004; 279(36): 37726 - 37733.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Saika, S. Kono-Saika, Y. Ohnishi, M. Sato, Y. Muragaki, A. Ooshima, K. C. Flanders, J. Yoo, M. Anzano, C.-Y. Liu, et al.
Smad3 Signaling Is Required for Epithelial-Mesenchymal Transition of Lens Epithelium after Injury
Am. J. Pathol., February 1, 2004; 164(2): 651 - 663.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P.-P. Kuang, R. H. Goldstein, Y. Liu, D. C. Rishikof, J.-C. Jean, and M. Joyce-Brady
Coordinate expression of fibulin-5/DANCE and elastin during lung injury repair
Am J Physiol Lung Cell Mol Physiol, November 1, 2003; 285(5): L1147 - L1152.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Y. P. Moodley, A. K. Scaffidi, N. L. Misso, C. Keerthisingam, R. J. McAnulty, G. J. Laurent, S. E. Mutsaers, P. J. Thompson, and D. A. Knight
Fibroblasts Isolated from Normal Lungs and Those with Idiopathic Pulmonary Fibrosis Differ in Interleukin-6/gp130-Mediated Cell Signaling and Proliferation
Am. J. Pathol., July 1, 2003; 163(1): 345 - 354.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Saika, T. Miyamoto, S.-i. Tanaka, T. Tanaka, I. Ishida, Y. Ohnishi, A. Ooshima, T. Ishiwata, G. Asano, T.-i. Chikama, et al.
Response of Lens Epithelial Cells to Injury: Role of Lumican in Epithelial-Mesenchymal Transition
Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 2094 - 2102.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Y. Moodley, P. Rigby, C. Bundell, S. Bunt, H. Hayashi, N. Misso, R. McAnulty, G. Laurent, A. Scaffidi, P. Thompson, et al.
Macrophage Recognition and Phagocytosis of Apoptotic Fibroblasts Is Critically Dependent on Fibroblast-Derived Thrombospondin 1 and CD36
Am. J. Pathol., March 1, 2003; 162(3): 771 - 779.
[Abstract] [Full Text] [PDF]




© The Company of Biologists Ltd 2001